# Liberation Bioindustries, Inc.
Liberation Bioindustries, Inc. (formerly Liberation Labs Holdings Inc.) is a New York-based, Delaware-incorporated contract precision-fermentation biomanufacturer founded in 2022, building a 600,000-liter commercial-scale fermentation plant in Richmond, Indiana.[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) • [2](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000001.txt) • [3](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-bioindustries-series-a1-equity-round/9308954) The company describes itself as a contract manufacturer of specialized ingredients made by precision fermentation (using microbes to brew specific proteins/ingredients) for customers in food, pharmaceuticals, specialty chemicals, plastics, and biofuels.[4](https://liberation.bio/) As of early 2026 its flagship plant was roughly 75% complete with construction paused while the company raised additional funds.[5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site)
| Fact | Detail |
|---|---|
| Founded | 2022, as Liberation Labs Holdings Inc. (Delaware corporation; name change recorded on EDGAR 2022-10-28)[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) |
| Headquarters | New York, NY (14 Wall Street per the December 2025 Form D)[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) |
| Business | Contract precision-fermentation biomanufacturing ("Biomanufacturing-as-a-Service")[4](https://liberation.bio/) • [6](https://liberation.bio/bio3-platform/) |
| Flagship facility | 600,000-liter plant, Richmond, Indiana; ~75% complete, construction paused (early 2026)[3](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-bioindustries-series-a1-equity-round/9308954) • [5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site) |
| SEC-disclosed amount sold | $112,147,322 across two Form D offerings (Feb 2025, Dec 2025)[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) • [2](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000001.txt) |
| Notable investors | Agronomics ($27M invested, carried at $46.8M), Siddhi Capital, NEOM Investment Fund[3](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-bioindustries-series-a1-equity-round/9308954) • [7](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-labs-closes-us-50-5-million-fundraise-/8712606) |
| Status | Active; no revenue yet per the December 2025 Form D[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) |
## History and founding
The company was incorporated in 2022 in Delaware as Liberation Labs Holdings Inc.; EDGAR records the former conformed name with a change date of October 28, 2022.[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) It raised a $20.0 million seed round on December 30, 2022, led by Agronomics and [Siddhi Capital](https://www.edgepedia.org/siddhi-capital) with CPT Capital, Thia Ventures, 8090 Industries, and Echo participating.[8](https://biobase.whitefordresearch.com/companies/liberation-bioindustries) It broke ground on the Richmond, Indiana facility in June 2023.[7](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-labs-closes-us-50-5-million-fundraise-/8712606)
On June 2, 2025 the company announced a rebrand from Liberation Labs to Liberation Bioindustries. Founder and then-CEO [Mark Warner](https://www.edgepedia.org/mark-warner) said the "Labs" part of the old name felt "unnecessarily limiting, if not outright confusing" as the company moved from concept to completion.[9](https://www.globenewswire.com/news-release/2025/06/02/3091930/0/en/Liberation-Labs-is-Now-Liberation-Bioindustries.html) The rebrand's announcement date sits oddly against the EDGAR former-name record of October 2022; the sources do not reconcile the two dates, and the February 2025 Form D was still filed under the Liberation Labs Holdings Inc. name.[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) • [2](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000001.txt) • [9](https://www.globenewswire.com/news-release/2025/06/02/3091930/0/en/Liberation-Labs-is-Now-Liberation-Bioindustries.html)
Leadership changed in early 2026: Etan Bendheim, previously chief business officer, moved to CEO in January, while Mark Warner, who spearheaded the Richmond project, stepped back from full-time CTO to a fractional CTO role. Warner said the change should not be read as a loss of confidence in the Richmond facility.[5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site) The December 2025 Form D, signed by Warner as CEO, lists Warner, James Mellon, Babar Khan, Steven Finn, and Philip Boigner as directors and Bendheim as an executive officer.[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt)
## Products, technology and facilities
The company's core offering is contract production of specialized ingredients using precision fermentation at commercial scale.[4](https://liberation.bio/) Its Bio3 platform is a design–build–operate model under which the company owns and operates plants and sells "Biomanufacturing-as-a-Service" capacity through long-term take-or-pay agreements, giving customers capital-light access to fermentation and purification capacity.[6](https://liberation.bio/bio3-platform/)
The flagship site in Richmond, Indiana is described by the company as the first commercial-scale, purpose-built precision fermentation facility of its kind, with 600,000 liters of initial fermentation capacity and room for expansion.[6](https://liberation.bio/bio3-platform/) The plant is designed around four 150,000-liter fermenters organized into two independent 300,000-liter operating trains, each with its own downstream processing.[5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site) Operations were scheduled to begin in early 2026.[9](https://www.globenewswire.com/news-release/2025/06/02/3091930/0/en/Liberation-Labs-is-Now-Liberation-Bioindustries.html) • [6](https://liberation.bio/bio3-platform/) A second site in Saudi Arabia is in the feasibility stage: in April 2025 the company announced a partnership with Topian, NEOM's food company, to design a precision fermentation facility there.[9](https://www.globenewswire.com/news-release/2025/06/02/3091930/0/en/Liberation-Labs-is-Now-Liberation-Bioindustries.html)
## Funding by the numbers
Two SEC Form D filings account for $112,147,322 in total amount sold. The February 10, 2025 filing, made under the Liberation Labs Holdings Inc. name, reported a $51,982,971 offering, fully sold, with a first sale date of January 28, 2025.[2](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000001.txt) The December 10, 2025 filing reported a $101,664,354 offering of which $60,164,351 was sold; $56,664,354 of that came from conversion of existing convertible notes, with the remainder in new cash.[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt)
The round-by-round record:[8](https://biobase.whitefordresearch.com/companies/liberation-bioindustries)
- $20.0 million seed, December 30, 2022 (Agronomics and Siddhi Capital led; CPT Capital, Thia Ventures, 8090 Industries, Echo participating)
- $30.0 million equipment financing, April 12, 2023
- $25.0 million USDA-backed loan guarantee via Ameris Bank, November 30, 2023
- $12.5 million secured convertible note, April 5, 2024 (Agronomics $10.0 million; Siddhi Capital participating)
- $3.5 million secured note, October 15, 2024 (Agronomics $2.0 million, with New Agrarian Company Limited, Galloway Limited, and Jim Mellon)
- $50.5 million convertible note round closed January 30, 2025: $31.5 million of new capital plus $19.0 million of insider bridge notes raised during 2024, with NEOM Investment Fund, Galloway Limited, Meach Cove Capital, Agronomics, New Agrarian Capital, and Siddhi Capital[7](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-labs-closes-us-50-5-million-fundraise-/8712606)
- Series A1 first close, December 19, 2025: New Agrarian subscribed $2.5 million and Agronomics converted existing loan notes plus accrued interest[8](https://biobase.whitefordresearch.com/companies/liberation-bioindustries)
Agronomics has invested US$27 million in total and, after the Series A1 round, carried its holding at US$46.8 million, about 23% of Agronomics' net asset value as of September 30, 2025.[3](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-bioindustries-series-a1-equity-round/9308954) Including public-sector awards and loan guarantees, the company said in January 2025 that it had raised US$125.5 million in deployable capital.[7](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-labs-closes-us-50-5-million-fundraise-/8712606) Aggregator figures differ: [CB Insights](https://www.edgepedia.org/cb-insights) lists $182.66 million over 13 rounds, but this is unverified and conflicts with the SEC record.[10](https://www.cbinsights.com/company/liberation-labs/financials)
## Business, customers and traction
The company serves customers across food, pharmaceuticals, specialty chemicals, plastics, and biofuels.[4](https://liberation.bio/) In May 2025 it announced it will produce commercial-scale volumes of Vivitein BLG, a dairy protein, for the Dutch protein company Vivici; Vivici is the only named prospective customer in press coverage.[9](https://www.globenewswire.com/news-release/2025/06/02/3091930/0/en/Liberation-Labs-is-Now-Liberation-Bioindustries.html) • [5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site) Bendheim claimed "qualified stated interest for well over 200% of the available capacity" at the Richmond site, a company statement not independently verified.[5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site)
Revenue remains zero: the December 2025 Form D states the issuer is not yet generating revenue.[1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) Bendheim described the funding gap plainly: the project is too capital-intensive for classic venture capital but does not yet generate the revenue needed for traditional project finance.[5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site)
## Recent developments
The company raised secured notes during 2024 ($12.5 million in April, $3.5 million in October), followed by the January 2025 $50.5 million convertible round, which brought in NEOM Investment Fund.[8](https://biobase.whitefordresearch.com/companies/liberation-bioindustries) • [7](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-labs-closes-us-50-5-million-fundraise-/8712606) 2025 brought the Topian partnership (April), the Vivici production agreement (May), the rebrand (June), and the December Form D and Series A1 first close.[9](https://www.globenewswire.com/news-release/2025/06/02/3091930/0/en/Liberation-Labs-is-Now-Liberation-Bioindustries.html) • [1](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt) • [8](https://biobase.whitefordresearch.com/companies/liberation-bioindustries) In early 2026, construction on the Richmond plant was paused at roughly 75% completion while the company sought funds to finish it; the site was originally due operational by the end of 2024.[5](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site)
## References
1. [SEC Form D, Liberation Bioindustries, Inc., filed 2025-12-10](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000004.txt)
2. [SEC Form D, Liberation Labs Holdings Inc., filed 2025-02-10](https://www.sec.gov/Archives/edgar/data/1952448/0001952448-25-000001.txt)
3. [Liberation Bioindustries Series A1 equity round (Agronomics RNS via Investegate)](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-bioindustries-series-a1-equity-round/9308954)
4. [Liberation Bioindustries company website](https://liberation.bio/)
5. [Liberation Bioindustries pauses US plant buildout amid funding gap (AgFunderNews)](https://agfundernews.com/liberation-bioindustries-pauses-construction-again-as-it-seeks-funds-to-complete-us-biomanufacturing-site)
6. [Bio3 Platform — Liberation Bioindustries](https://liberation.bio/bio3-platform/)
7. [Liberation Labs Closes US$50.5 million Fundraise (Agronomics RNS via Investegate)](https://www.investegate.co.uk/announcement/rns/agronomics-limited--anic/liberation-labs-closes-us-50-5-million-fundraise-/8712606)
8. [Liberation Bioindustries — Whiteford Research Biobase](https://biobase.whitefordresearch.com/companies/liberation-bioindustries)
9. [Liberation Labs is Now Liberation Bioindustries (GlobeNewswire, June 2, 2025)](https://www.globenewswire.com/news-release/2025/06/02/3091930/0/en/Liberation-Labs-is-Now-Liberation-Bioindustries.html)
10. [CB Insights financials page for Liberation Bioindustries](https://www.cbinsights.com/company/liberation-labs/financials)
---
*Topic: Encyclopedia › Society and history › Economics and business › Business and work › Business and work overview › Companies and corporations › Venture-backed startups and growth companies › Health, biotech, and medtech startups › Contract development and manufacturing organizations*
*Initially written Sep 17, 2026 · Edited: Oct 11, 2026; Oct 15, 2026*
*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*
License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license